Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: waldo who wrote (27166)	12/12/1998 10:38:00 PM
From: Archie Goodwin	Read Replies (3) \| Respond to of 119973

ASTM Don't forget the L.A. Times latimes.com; Ran today. Regards A.G.

To: waldo who wrote (27166)	12/12/1998 10:39:00 PM
From: Gregg Sterner	Read Replies (1) \| Respond to of 119973

Here's the WSJ & DJ composit article.... Dow Jones Newswires -- December 7, 1998 Aastrom Biosci: Studies Show Safety Of Cell Production Sys MIAMI (Dow Jones)--Aastrom Biosciences Inc. (ASTM) said results from four clinical studies showed the safety and utility of its AastromReplicell cell production system. In a press release Monday, the biotechnology company said it will use the results to support European marketing efforts beginning later this year. The automated clinical system that allows hospitals to produce patient-specific cells for treating cancer and other ailments. The company received initial approval in October to affix the CE Mark on the system.